Automated Platforms
The KIT is currently running 4 fully automated platforms that are of a high strategic relevance for the field of Health Technologies
•ChemASAP: Personalized medicine
•BioMAT Foundry: Bioinks development for 3D printing of organ on a chip models and soft tissues
•SynGen: Large DNA Synthesis platform for synthetic genomes
•DSRT platform (droplet microarray): personalized drug testing
